AI news story

AI-Designed Drugs by a DeepMind Spinoff Are Headed to Human Trials

Isomorphic Labs president Max Jaderberg said at WIRED Health in London that the startup has built a “broad and exciting pipeline of new medicines.”

  • Startups
  • Source: WIRED
  • Published: 2026-04-24
  • Signal score: 3
  • 19 sources

Editor's take

Isomorphic Labs, a DeepMind spinoff, is advancing AI-discovered drug candidates into human clinical trials, signaling a significant step beyond preclinical research for AI-driven drug discovery. This transition is crucial as it moves beyond theoretical potential to tangible therapeutic evaluation, potentially impacting patients with unmet medical needs and validating the investment in AI for pharmaceutical R&D, a field long dominated by traditional, iterative processes.

The immediate focus will be on the success of these early-stage trials. Observing whether Isomorphic's AI-identified molecules demonstrate efficacy and safety comparable to or exceeding human-designed therapies will be key. Furthermore, the speed and cost-effectiveness of this AI-driven pipeline, especially compared to established pharmaceutical giants like Pfizer or Merck, will determine broader industry adoption and the long-term viability of this approach.

Signal score: 3

This event was corroborated by 19 independent sources. The signal score weighs cross-source corroboration, recency, source weight and topic salience. How we rank stories.

Original reporting

This story summarises reporting published by WIRED. Read the original article at WIRED.

More Startups stories

  1. Valar Atomics Raises $1 Billion to Power the AI Era

    Bloomberg · 2026-08-03

    Valar Atomics, the company building America's first gigasites, secured $1 billion in its Series B funding round led by Sequoia.

  2. Horizon3 Raises $250 Million Series E at Over $2 Billion Valuation to Expand Autonomous AI Penetration Testing

    Unite.AI · 2026-08-03

    Horizon3 has raised $250 million in Series E funding at a valuation exceeding $2 billion, giving the cybersecurity company substantial new capital to expand its autonomous

  3. Zenity Raises $125 Million as Enterprises Confront the Security Risks of Autonomous AI Agents

    Unite.AI · 2026-08-03

    Zenity has raised $125 million in Series C funding as businesses move artificial intelligence agents from controlled experiments into systems capable of accessing data

  4. A Marc Benioff-backed startup thinks AI can solve the AI deployment problem

    TechCrunch · 2026-08-03

    June emerged from stealth today with a $20 million pre-seed round to make AI adoption simpler.

  5. AI Chip Designer DeepX’s Value Surges to $2.2 Billion in Funding

    Bloomberg · 2026-08-03

    South Korean AI chip designer DeepX Co. has secured fresh funding at roughly four times its previous valuation

  6. A real macOS flaw worth $200K went unreported because Apple's bug bounty inbox was full of AI slop

    The Decoder · 2026-08-02

    Apple's bug bounty program is drowning in AI-generated bug reports. The company has capped submissions per researcher because fabricated reports are clogging the review pipeline.